Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma

Arezoo Aghakhani1, Rasool Hamkar, Nastaran Zamani

  • 1Clinical Research Department, Pasteur Institute of Iran, No. 69, Pasteur Ave., Tehran 13164, Iran. aaghakhani@pasteur.ac.ir

Insights

Hepatitis B virus (HBV) genotype D is the sole detectable genotype in Iranian patients with hepatocellular carcinoma (HCC). This finding confirms previous research on HBV infection in Iran.

Area of Science:

  • Hepatology
  • Virology
  • Oncology

Background:

  • Chronic hepatitis B virus (HBV) infection is a significant risk factor for hepatocellular carcinoma (HCC).
  • HBV is the predominant cause of HCC in Iran.
  • Previous studies have not determined HBV genotypes in Iranian HCC patients.

Purpose of the Study:

  • To determine the HBV genotype in Iranian patients diagnosed with HCC.
  • To investigate the prevalence of specific HBV genotypes associated with liver cancer in Iran.

Main Methods:

  • Analysis of paraffin-embedded HCC tissue samples from 40 patients.
  • Nested PCR-mediated amplification and sequencing of HBV DNA.
  • Phylogenetic analysis to determine HBV genotype by comparison with GenBank sequences.

Main Results:

  • Phylogenetic analysis confirmed that all analyzed HBV isolates belonged to genotype D.
  • No other HBV genotypes were detected in the study cohort.

Conclusions:

  • Genotype D is the only detectable HBV genotype in various clinical forms of HBV infection in Iran.
  • These findings align with existing reports on HBV genotypes within the Iranian population.
Abstract